Skip to main content

ZEVRA THERAPEUTICS INC

For the period ended Dec 31, 2024. Filed Mar 12, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 12, 2025

ZVRA$11.92-1.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Power of Attorney (included on signature page)

POWER OF ATTORNEY

KNOW ALL BY THESE PRESENTS, that each person whose signature appears below hereby constitute and appoint Neil F. McFarlane and R. LaDuane Clifton, and each of them (with full power to each of them to act alone), as his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them for him and in his name, place and stead, and in any and all capacities, to sign any and all amendments to this report, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/s/ Neil F. McFarlane
Neil F. McFarlanePresident and Chief Executive Officer (Principal Executive Officer)March 12, 2025
/s/ R. LaDuane Clifton
R. LaDuane Clifton, MBA, CPAChief Financial Officer and Treasurer (Principal Financial Officer)March 12, 2025
/s/ Timothy J. Sangiovanni
Timothy J. Sangiovanni, CPASenior Vice President, Finance and Corporate Controller (Principal Accounting Officer)March 12, 2025
/s/ Thomas D. Anderson
Thomas D. AndersonDirectorMarch 12, 2025
/s/ John B. Bode
John B. BodeDirectorMarch 12, 2025
/s/ Douglas W. Calder
Douglas W. CalderDirectorMarch 12, 2025
/s/Wendy Dixon
Wendy DixonDirectorMarch 12, 2025
/s/ Tamara A. Favorito
Tamara A. FavoritoDirectorMarch 12, 2025
/s/ Alvin Shih
Alvin ShihDirectorMarch 12, 2025
/s/ Corey Watton
Corey WattonDirectorMarch 12, 2025
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.